Page 1 of Clinical Trials for NK Cell, 477 Total Matches
- 1RecruitingLast Updated: September 23, 2009Condition(s): Myeloblastic Leukemia
- 2RecruitingLast Updated: December 22, 2011Condition(s): Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma
- 3TerminatedLast Updated: September 22, 2010Condition(s): Leukemia; Lymphoma
- 4Active, not recruitingLast Updated: February 21, 2012Condition(s): Lymphoma
- 5RecruitingLast Updated: October 13, 2010Condition(s): Acute Myeloid Leukemias; Advanced Hematological Malignancies; Indication for Allogeneic Stem Cell Transplantation; no HLA-identical Donor Available
- 6RecruitingLast Updated: February 18, 2009Condition(s): Melanoma
- 7CompletedLast Updated: May 24, 2012Condition(s): Leukemia; Pediatrics
- 8RecruitingLast Updated: April 17, 2012Condition(s): Acute Myeloid Leukemia; Myelodysplastic Syndrome
- 9TerminatedLast Updated: December 20, 2011Condition(s): Leukemia
- 10Active, not recruitingLast Updated: September 28, 2011Condition(s): Neuroblastoma
- 11Active, not recruitingLast Updated: September 1, 2011Condition(s): Lymphoma; Leukemia; Stem Cell Transplantation
- 12TerminatedLast Updated: January 20, 2010Condition(s): Leukemia; Myelodysplastic Syndromes
- 13RecruitingLast Updated: April 18, 2011Condition(s): Childhood Solid Tumor
- 14Active, not recruitingLast Updated: October 31, 2011Condition(s): Lymphoma; Myeloma; Leukemia
- 15WithdrawnLast Updated: March 22, 2012Condition(s): Haematological Malignancies; Allogeneic Stem Cell Transplant; CD56+CD3- NK Cells
- 16RecruitingLast Updated: March 9, 2012Condition(s): Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Acute, T-Cell; Juvenile Myelomonocytic Leukemia Lymphoblastic; T-cell Lymphoblastic Lymphoma; Myelodysplastic Syndrome
- 17Active, not recruitingLast Updated: February 21, 2012Condition(s): Lymphoma
- 18Enrolling by invitationLast Updated: June 26, 2011Condition(s): Diffuse Large B-cell Lymphoma
- 19Active, not recruitingLast Updated: September 27, 2011Condition(s): Acute Myelogenous Leukemia
- 20Active, not recruitingHaploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)Last Updated: September 13, 2011Condition(s): Leukemia, Myelogenous, Acute
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=NK+Cell
